UK scientists slam Tamiflu drug in ongoing debate

April 10, 2014

British scientists say there isn't enough evidence to prove the antiviral drug Tamiflu reduces the spread of flu.

The findings published Thursday in the journal BMJ question whether governments worldwide were justified in spending millions on the drug during the 2009 swine flu pandemic.

Researchers at the Cochrane Collaboration and BMJ have long argued there weren't enough trials to prove Tamiflu works and say after getting access to internal trials conducted by its maker, Roche AG, they found Tamiflu reduces by about a half a day in adults but has little effect in children. Compared to people taking a placebo pill, there was no proof people taking Tamiflu were less likely to be hospitalized or suffer serious .

Experts not involved in the research pointed out that Tamiflu works best when given early and that it's hard for doctors to catch people at that stage.

"It's not that the drugs don't work, it's just difficult to use them to their best effect," said Wendy Barclay, an influenza expert at Imperial College London, in a statement. She cited some problems with the way scientists at the Cochrane group and BMJ interpreted the data and said it was wise of governments to stockpile Tamiflu since there are few drugs available to treat flu. "If another pandemic came tomorrow and the (U.K.) government had no drug with which to treat thousands of (flu) patients, I imagine there would be a public outcry."

Swiss pharmaceutical Roche said they "fundamentally disagree" with the overall conclusions of the BMJ series and said more than 100 countries have approved Tamiflu worldwide. The U.S. spent more than $1.3 billion on its antiviral stockpile while Britain spent nearly $711 million on Tamiflu in its pandemic preparations, according to government documents cited by the Cochrane group and BMJ.

Public health agencies including the World Health Organization and the U.S. Centers for Disease Control and Prevention continue to recommend Tamiflu be used to treat flu and say it has proven helpful in treating patients with novel strains like .

Explore further: Tamiflu-resistant swine flu patient found in Japan: govt

More information: Tamiflu and Relenza: How effective are they?

www.bmj.com/tamiflu

Related Stories

WHO says Tamiflu still works against swine flu

November 26, 2009

(AP) -- The World Health Organization says isolated cases of drug-resistant swine flu in Britain and the United States have not changed the agency's assessment of the disease.

British researchers: little evidence Tamiflu works

December 8, 2009

(AP) -- British researchers say there is little evidence Tamiflu stops complications in healthy people who catch the flu, though public health officials contend the swine flu drug reduces flu hospitalizations and deaths.

Preparing for Tamiflu-resistant influenza viruses

December 9, 2013

Researchers in Umeå and Uppsala have found that residues of the influenza drug Tamiflu in our environment can make the influenza virus in birds resistant. This can have serious consequences in the event of an influenza pandemic. ...

Recommended for you

Treatment options for opioid addiction are expanding

August 10, 2016

In the past two decades, the devastation associated with opioid addiction has escaped the relative confines of the inner city and extended to suburban and rural America. Due in large part to the proliferation of prescription ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.